Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors

The introduction of nucleot(s)ide analogues (NAs) for oral antiviral therapy has dramatically improved the clinical outcome of patients with chronic hepatitis B. NAs appear to be safe and induce potent suppression of viral replication. However, they are associated with a low rate of HBsAg serocleara...

Descripción completa

Detalles Bibliográficos
Autores principales: Kranidioti, Hariklia, Manolakopoulos, Spilios, Khakoo, Salim I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2015
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367206/
https://www.ncbi.nlm.nih.gov/pubmed/25831071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367206/
https://www.ncbi.nlm.nih.gov/pubmed/25831071

Ejemplares similares